Matches in Wikidata for { <http://www.wikidata.org/entity/Q65332164> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q65332164 description "clinical trial" @default.
- Q65332164 description "ensayu clínicu" @default.
- Q65332164 description "klinisch onderzoek" @default.
- Q65332164 description "клінічне випробування" @default.
- Q65332164 name "Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer" @default.
- Q65332164 name "Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer" @default.
- Q65332164 type Item @default.
- Q65332164 label "Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer" @default.
- Q65332164 label "Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer" @default.
- Q65332164 prefLabel "Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer" @default.
- Q65332164 prefLabel "Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer" @default.
- Q65332164 P1132 Q65332164-8D173AE6-FED0-4EE4-9D29-5A44E15E1523 @default.
- Q65332164 P1476 Q65332164-8E1B6928-BD9A-464F-BB7B-A06111BED4FC @default.
- Q65332164 P17 Q65332164-D6CC5818-657E-4B6E-BECF-E4BF6A3EDF90 @default.
- Q65332164 P2899 Q65332164-4317C4EF-8A73-4F3A-AA28-8520A6A63403 @default.
- Q65332164 P3098 Q65332164-A2462798-C852-4109-A83C-7F63E2A07CFA @default.
- Q65332164 P31 Q65332164-0B93F460-CB49-491F-AB4C-8527D9530F8C @default.
- Q65332164 P580 Q65332164-4F939034-22D1-4AEC-921F-E99BEA2CF4ED @default.
- Q65332164 P582 Q65332164-09273F07-B106-44ED-A34D-88C9ED93CF8B @default.
- Q65332164 P6099 Q65332164-A413BC78-2117-432A-BE27-77A082A0FA33 @default.
- Q65332164 P8363 Q65332164-1DB9D451-EF4B-44FF-AAB9-5AAA9AA00AC6 @default.
- Q65332164 P1132 "+74" @default.
- Q65332164 P1476 "A Phase 1a/1b Dose Escalation and Expansion Study of SC-003 as a Single-Agent and in Combination With ABBV-181 in Subjects With Platinum-Resistant/ Refractory Ovarian Cancer" @default.
- Q65332164 P17 Q30 @default.
- Q65332164 P2899 "+18" @default.
- Q65332164 P3098 "NCT02539719" @default.
- Q65332164 P31 Q30612 @default.
- Q65332164 P580 "2015-08-01T00:00:00Z" @default.
- Q65332164 P582 "2019-01-02T00:00:00Z" @default.
- Q65332164 P6099 Q5452194 @default.
- Q65332164 P8363 Q78089383 @default.